Genpharmasec Shareholding Pattern

As of Sept 2025, Genpharmasec (GENPHARMA) promoter holding 29.98%, FII 0.00%, DII 0.00%, public 60.19%, total shareholders 105,804. For live price, key ratios and the full company profile, see GENPHARMA stock price BSE.

Promoter Holding 29.98%
FII Holding 0.00%
DII Holding 0.00%
Public Holding 60.19%
Total Shareholders 105,804
As of Sept 2025

GENPHARMA Recent Shareholding Changes — Promoter, FII & DII

Genpharmasec promoter, FII and DII holding change from Jun 2025 to Sept 2025. Examine GENPHARMA quarterly performance for recent quarterly revenue, profit and EPS trends.

Promoter Holding Change
Jun 2025 to Sept 2025
No Change
FII Holding Change
Jun 2025 to Sept 2025
No Change
DII Holding Change
Jun 2025 to Sept 2025
No Change
Public Holding Change
Jun 2025 to Sept 2025
+0.16%

Genpharmasec Quarterly Shareholding Trend — Promoter, FII, DII & Public

GENPHARMA promoter, FII, DII, public and government holding % by quarter — institutional ownership and promoter pledge trends. Review Genpharmasec P/E valuation to evaluate earnings-based valuation against sector peers.

Promoter
FII
DII
Public
Government

GENPHARMA Shareholding Pattern Data — Quarterly History

Genpharmasec quarterly promoter, FII, DII, public holding % and total shareholders. Download as Excel or CSV.

Period Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Sept 2025 29.98% 0.00% 0.00% 0.00% 60.19% 9.83% 100.00% 105,804
Jun 2025 29.98% 0.00% 0.00% 0.00% 60.03% 9.99% 100.00% 107,602
Mar 2025 29.98% 0.00% 0.00% 0.00% 59.94% 10.08% 100.00% 109,080
Dec 2024 29.98% 0.00% 0.00% 0.00% 59.62% 10.40% 100.00% 109,206
Sept 2024 29.98% 0.00% 0.00% 0.00% 59.55% 10.47% 100.00% 105,838
Jun 2024 29.98% 0.00% 0.00% 0.00% 61.26% 8.76% 100.00% 108,220
Mar 2024 29.98% 0.00% 0.00% 0.00% 56.17% 13.84% 99.99% 108,137
Feb 2024 29.98% 0.00% 0.00% 0.00% 52.78% 17.24% 100.00% 105,693
Dec 2023 59.96% 0.00% 0.00% 0.00% 33.81% 6.23% 100.00% 89,438
Sept 2023 59.96% 0.00% 0.00% 0.00% 32.82% 7.21% 99.99% 54,458
Jun 2023 59.96% 0.00% 0.00% 0.00% 31.81% 8.23% 100.00% 48,868
Mar 2023 59.96% 0.00% 0.00% 0.00% 30.13% 9.91% 100.00% 49,760
Dec 2022 59.96% 0.00% 0.00% 0.00% 30.57% 9.47% 100.00% 53,266
Sept 2022 59.96% 0.00% 0.00% 0.00% 30.58% 9.46% 100.00% 53,404
Jun 2022 59.96% 0.00% 0.00% 0.00% 30.36% 9.68% 100.00% 54,007
Mar 2022 59.96% 0.00% 0.00% 0.00% 30.02% 10.03% 100.01% 24,134
Dec 2021 59.96% 0.00% 0.00% 0.00% 26.18% 13.86% 100.00% 17,121
Sept 2021 59.96% 0.00% 0.00% 0.00% 25.21% 14.83% 100.00% 9,559
Jun 2021 59.96% 0.00% 0.00% 0.00% 24.43% 15.61% 100.00% 6,265
Mar 2021 59.96% 0.00% 0.00% 0.00% 24.56% 15.49% 100.01% 0
Quarter Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Sept 2025 29.98% 0.00% 0.00% 0.00% 60.19% 9.83% 100.00% 105,804
Jun 2025 29.98% 0.00% 0.00% 0.00% 60.03% 9.99% 100.00% 107,602
Mar 2025 29.98% 0.00% 0.00% 0.00% 59.94% 10.08% 100.00% 109,080
Dec 2024 29.98% 0.00% 0.00% 0.00% 59.62% 10.40% 100.00% 109,206
Sept 2024 29.98% 0.00% 0.00% 0.00% 59.55% 10.47% 100.00% 105,838
Jun 2024 29.98% 0.00% 0.00% 0.00% 61.26% 8.76% 100.00% 108,220
Mar 2024 29.98% 0.00% 0.00% 0.00% 56.17% 13.84% 99.99% 108,137
Feb 2024 29.98% 0.00% 0.00% 0.00% 52.78% 17.24% 100.00% 105,693
Dec 2023 59.96% 0.00% 0.00% 0.00% 33.81% 6.23% 100.00% 89,438
Sept 2023 59.96% 0.00% 0.00% 0.00% 32.82% 7.21% 99.99% 54,458
Jun 2023 59.96% 0.00% 0.00% 0.00% 31.81% 8.23% 100.00% 48,868
Mar 2023 59.96% 0.00% 0.00% 0.00% 30.13% 9.91% 100.00% 49,760
Year Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Mar 2025 29.98% 0.00% 0.00% 0.00% 59.94% 10.08% 100.00% 109,080
Dec 2024 29.98% 0.00% 0.00% 0.00% 59.62% 10.40% 100.00% 109,206
Dec 2023 59.96% 0.00% 0.00% 0.00% 33.81% 6.23% 100.00% 89,438
Dec 2022 59.96% 0.00% 0.00% 0.00% 30.57% 9.47% 100.00% 53,266
Dec 2021 59.96% 0.00% 0.00% 0.00% 26.18% 13.86% 100.00% 17,121